Genomma Lab Internacional SAB De CV (GNMLF)

Currency in USD
1.09
0.00(0.00%)
Delayed Data·
GNMLF Scorecard
Full Analysis
Trading at a low P/E ratio relative to near-term earnings growth
GNMLF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.091.09
52 wk Range
0.971.43
Key Statistics
Prev. Close
1.09
Open
1.09
Day's Range
1.09-1.09
52 wk Range
0.97-1.43
Volume
-
Average Volume (3m)
1.64K
1-Year Change
11.22%
Book Value / Share
0.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
GNMLF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral

Genomma Lab Internacional SAB De CV Company Profile

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Mexico and internationally. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and improvement products, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, infant nutrition, and others. Genomma Lab Internacional, S.A.B. de C.V. was incorporated in 1996 and is based in Mexico City, Mexico.

Employees
1624

Compare GNMLF to Peers and Sector

Metrics to compare
GNMLF
Peers
Sector
Relationship
P/E Ratio
9.3x14.2x−0.5x
PEG Ratio
0.100.010.00
Price/Book
1.8x1.3x2.6x
Price / LTM Sales
1.1x1.7x3.2x
Upside (Analyst Target)
-14.8%40.5%
Fair Value Upside
Unlock25.2%4.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.99%
Dividend Yield
-
Industry Median 2.83%
Annualised payout
-
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 30, 2025
EPS / Forecast
0.51 / --
Revenue / Forecast
4.41B / --
EPS Revisions
Last 90 days

GNMLF Income Statement

People Also Watch

193.75
AC
0.00%
223.00
PINFRA
0.00%
181.02
FEMSAUBD
0.00%
42.270
BBAJIOO
0.00%
44.680
GENTERA
0.00%

FAQ

What Stock Exchange Does Genomma Lab Internacional SAB De CV Trade On?

Genomma Lab Internacional SAB De CV is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Genomma Lab Internacional SAB De CV?

The stock symbol for Genomma Lab Internacional SAB De CV is "GNMLF."

What Is the Genomma Lab Internacional SAB De CV Market Cap?

As of today, Genomma Lab Internacional SAB De CV market cap is 1.09B.

What Is Genomma Lab Internacional SAB De CV's Earnings Per Share (TTM)?

The Genomma Lab Internacional SAB De CV EPS (TTM) is 1.99.

From a Technical Analysis Perspective, Is GNMLF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Genomma Lab Internacional SAB De CV Stock Split?

Genomma Lab Internacional SAB De CV has split 0 times.

How Many Employees Does Genomma Lab Internacional SAB De CV Have?

Genomma Lab Internacional SAB De CV has 1624 employees.

What is the current trading status of Genomma Lab Internacional SAB De CV (GNMLF)?

As of 25 Jul 2025, Genomma Lab Internacional SAB De CV (GNMLF) is trading at a price of 1.09, with a previous close of 1.09. The stock has fluctuated within a day range of 1.09 to 1.09, while its 52-week range spans from 0.97 to 1.43.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.